Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry

• Understanding uncertainty in the COVID-19 pandemic is a priority for the industry. • Policy and population behavioral affect risk management in the short/mid-term. • Information around natural history unknowns will guide long-term risk management. • Our framework allows risk management and risk-sh...

Descripción completa

Detalles Bibliográficos
Autores principales: Coudeville, L., Gomez, G.B., Jollivet, O., Harris, R.C., Thommes, E., Druelles, S., Chit, A., Chaves, S.S., Mahé, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552977/
https://www.ncbi.nlm.nih.gov/pubmed/33097312
http://dx.doi.org/10.1016/j.vaccine.2020.10.034
Descripción
Sumario:• Understanding uncertainty in the COVID-19 pandemic is a priority for the industry. • Policy and population behavioral affect risk management in the short/mid-term. • Information around natural history unknowns will guide long-term risk management. • Our framework allows risk management and risk-sharing strategies discussions.

Ejemplares similares